B CELL ALL
Clinical trials for B CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B CELL ALL trials appear
Sign up with your email to follow new studies for B CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Resort leukemia treatment made available through expanded access program
Disease control AVAILABLEThis expanded access program provides an experimental CAR-T cell therapy called obe-cel to adults with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) who have no other treatment options. The therapy is made from the patient's own blood cells but did not meet com…
Matched conditions: B CELL ALL
Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Leukemia treatment may erase vaccine protection—study tests if re-vaccination works
Knowledge-focused Recruiting nowThis study looks at whether children and young adults (up to age 21) treated for B-cell acute lymphoblastic leukemia with the immunotherapy drug blinatumomab still have protection from routine childhood vaccines. Researchers will measure antibody levels for diseases like tetanus,…
Matched conditions: B CELL ALL
Sponsor: Arkansas Children's Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC